Phase I/II clinical trial of anti-OX40, radiation and cyclophosphamide in patients with prostate cancer: immunological analysis
Magdalena Kovacsovics-Bankowski, Lana Chisholm, Jonna Vercellini, Marka Crittenden, Scot Lary, Brendan Curti, Andrew Weinberg
Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P255; DOI: 10.1186/2051-1426-1-S1-P255
